Subject(s)
Breast Neoplasms , Phyllodes Tumor , Breast Neoplasms/pathology , Child , Female , Humans , Phyllodes Tumor/pathologyABSTRACT
The authors give an account of a group of 53 patients with injuries of the acral blood vessels, treated at the hospital and policlinic in Banská Bystrica between Jan. 1, 1979 and Dec. 31, 1988. They discuss the frequency, incidence, site of injury, method of treatment of acral blood vessels and the results, as well as the number of diseases treated by surgeons with different specializations.
Subject(s)
Blood Vessels/injuries , Extremities/blood supply , Adolescent , Adult , Aged , Child , Humans , Middle Aged , Vascular Surgical Procedures , Wounds and Injuries/surgeryABSTRACT
The authors investigated the incidence of postoperative complications in 94 patients with diffuse purulent peritonitis after perforated appendicitis in the material of the surgical department of the Regional Institute of National Health in Banská Bystrica in the course of seven years. Most frequently they observed infections of wounds, intraperitoneal abscesses, early adhesive ileus with a mortality of 1.0%. The authors draw attention to the importance of early and accurate diagnosis and the urgency of surgical treatment as the best prevention of the development of peritonitis and serious postoperative complications.
Subject(s)
Appendicitis/complications , Intestinal Perforation/complications , Peritonitis/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Humans , Infant , Middle Aged , Peritonitis/drug therapy , Peritonitis/microbiology , Postoperative Complications , Rupture, SpontaneousABSTRACT
The authors present results of modality and immunomodulating treatment of breast cancer. In the treatment they use levamizole (Decaris) which has useful properties, as compared with other immunomodulating drugs--accurate dosage, simple administration and good tolerance. In a group of 84 patients it was administered after operation after adjuvant chemotherapy with Cyclophosphamide in a total dose of 300 mg orally, making check-up examinations of leucocytes and thrombocytes. As to other laboratory parameters, the authors assessed transaminases, alkaline phosphate, immunoglobulin, T-lymphocytes and carcinoembryonic antigen. During the same period the survival of patients in this group was significantly higher, as compared with a group of patients formerly treated by adjuvant chemotherapy with Cyclophosphamide without levamizole. Comparison of the results with those of other authors indicates that it is correct to include immunomodulating treatment in comprehensive treatment of breast cancer.
